Publication
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status
Results From the EMPEROR-Reduced Trial
Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Muhammad Shahzeb Khan, Nikolaus Marx, Carolyn S.P. Lam, Sven Schnaidt, Anne Pernille Ofstad, Martina Brueckmann, Waheed Jamal, Edimar A. Bocchi, Piotr Ponikowski, Sergio V. Perrone, James L. Januzzi, Subodh Verma, Michael Böhm, João Pedro Ferreira, Stuart J. Pocock, Faiez Zannad, Milton Packer
Circulation, January 2021, Wolters Kluwer Health
DOI: 10.1161/circulationaha.120.051824